Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens
about
Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urineA high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat ModelQuantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.Nails are a potential alternative matrix to hair for drug analysis in general unknown screenings by liquid-chromatography quadrupole time-of-flight mass spectrometry.Improved identification of multiple drugs of abuse and relative metabolites in urine samples using liquid chromatography/triple quadrupole mass spectrometry coupled with a library search.Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.Compound identification in forensic toxicological analysis with untargeted LC-MS-based techniques.Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching.Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry.Multi-target screening of biological samples using LC-MS/MS: focus on chromatographic innovations.Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.Assessing cocaine abuse using LC-MS/MS measurements in biological specimens.High-resolution mass spectrometry in toxicology: current status and future perspectives.Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS.Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.Comprehensive analysis of "bath salts" purchased from California stores and the internet.A Case Report of Fatal Desmethyl Carbodenafil Toxicity.Fatal Intoxication Involving 3-MeO-PCP: A Case Report and Validated Method.Identification of the Synthetic Cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in Plant Material and Quantification in Post-Mortem Blood Samples.MS-Based Analytical Techniques: Advances in Spray-Based Methods and EI-LC-MS Applications.Simple screening procedure for 72 synthetic cannabinoids in whole blood by liquid chromatography-tandem mass spectrometry.Identification and quantification of 4′-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC–TOF-MS in an autopsy caseThe use of RP-HPLC-Q-TOF-MS as a powerful tool for wastewater composition profiling and selection of water pollution marker specific to wastewater contamination
P2860
Q34022671-42B4365A-CABB-4E68-86E5-BFEF8114CDBFQ34364856-F8EA6267-2FDC-42A7-A285-151D4D281D77Q34499961-14E3C7E3-550F-400C-BBEA-23F1314506F8Q35187100-A4CF220C-9BDF-4A69-8804-EB8118CAA1FFQ35209034-702D4BB9-38DD-4077-9037-485FB7330CFFQ35231662-1C37E147-DA27-42E9-8A3A-44049EF71858Q35254099-A9BADBE3-A31B-4946-9FBA-0FB250988F19Q35840290-EF1A9572-25AC-4636-AA9E-A3E7DD58A561Q36088120-99D44F9F-B4A5-4500-B371-5CF2FD672035Q37658304-B0633EA9-3735-4E25-878F-BA5A4F4A8F07Q38221657-A467B94E-2720-4833-9C15-BDEF24E657F2Q38411456-BD8A3227-73B6-46E0-B841-A950FEB2B128Q38546015-CCA9E908-5D69-4A1F-A2C4-4BE8B400E069Q38846184-550B6777-95BF-4B34-9BA5-9223386F6950Q39157890-C4AA212A-F803-4204-A57A-BFBB4E7DB6D7Q39172040-05782F16-DE5D-45E6-9B97-BB8BE77E3462Q46104725-88962CB0-900B-4551-96EF-B56DF1A62090Q46442539-0B1D7614-7F0A-4C65-B0D1-506216D78D53Q46527965-320253D4-838F-4317-957E-0E3064C1AC22Q47866230-E0C74E77-62E5-4FD8-8EFB-7CFD94FE948BQ54982956-B9ADE3EC-9A2B-487E-A2AE-F06587C07A95Q55425177-E6FF8D81-ECE9-46B9-948B-D604B3E4FD32Q56532317-973DF28C-855A-4314-914C-759E25CDF207Q58792923-42D3ACFB-F21C-42D6-B127-D7065FF93B29
P2860
Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Validation of LC-TOF-MS screen ...... forensic toxicology specimens
@ast
Validation of LC-TOF-MS screen ...... forensic toxicology specimens
@en
type
label
Validation of LC-TOF-MS screen ...... forensic toxicology specimens
@ast
Validation of LC-TOF-MS screen ...... forensic toxicology specimens
@en
prefLabel
Validation of LC-TOF-MS screen ...... forensic toxicology specimens
@ast
Validation of LC-TOF-MS screen ...... forensic toxicology specimens
@en
P2093
P2860
P356
P1476
Validation of LC-TOF-MS screen ...... forensic toxicology specimens
@en
P2093
Anna T Kelly
Ashraf Mozayani
Crystal Arndt
Fessessework Guale
Hsin-Hung Chen
Jeffrey P Walterscheid
Shahriar Shahreza
P2860
P356
10.1093/JAT/BKS084
P577
2012-11-01T00:00:00Z